Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

The FDA has approved three new pediatric indications for somapacitan-beco, a once-weekly, long-acting growth hormone injection, according to a press release issued by Novo Nordisk.Somapacitan-beco ...

Novo Nordisk’s Sogroya is now approved for children aged 2.5 or older with idiopathic short stature, small for gestational age, and Noonan Syndrome.

IVF hormone injections are an advanced fertility treatment that helps your ovaries make more eggs, supporting your IVF cycles and achieving healthy eggs. Doctors administer these hormonal injections ...

FDA expands Sogroya approval for pediatric patients with Noonan syndrome, idiopathic short stature, and those born small for gestational age.

WASHINGTON -- Children who are healthy but abnormally short will be able to have injections of growth hormone in hopes of gaining 1 to 3 more inches of height, the Food and Drug Administration said ...

A comparison of morning and evening growth hormone injection schedules in children with growth disorders showed no significant differences in sleep-wake patterns, sleep duration, or daytime activity, ...

Growth hormone helps children grow in height and supports healthy metabolism. When a child does not have enough of this hormone, their growth may be slow. This is sometimes called growth failure.

In 2002, one out every eight babies was born prematurely. Doctors say many complications can occur when a baby arrives too early. Hormone injections may help women carry their babies to full term.

After rejecting it a year ago, the FDA approved once-daily palopegteriparatide (Yorvipath) for adults with hypoparathyroidism, drugmaker Ascendis Pharma announced on Monday. Injectable ...

Five people appear to have developed Alzheimer’s disease after receiving growth hormones from deceased donors’ brains as children. Although based on a small group of people, this suggests that the ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for ...